BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29970546)

  • 1. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
    Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
    Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
    BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
    Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
    Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
    Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
    Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
    Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
    Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
    Tian J; Liang Y; Qu P
    Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
    Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
    Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin use and endometrial cancer survival.
    Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
    Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
    Xie H; Li M; Zheng Y
    Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
    Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
    Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.
    Urpilainen E; Arima R; Karihtala P; Puistola U; Ahtikoski A
    Anticancer Res; 2021 Feb; 41(2):821-828. PubMed ID: 33517287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.